Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO - PubMed (original) (raw)
. 2003 Feb;284(2):H683-90.
doi: 10.1152/ajpheart.00567.2002. Epub 2002 Oct 3.
Affiliations
- PMID: 12388218
- DOI: 10.1152/ajpheart.00567.2002
Free article
Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO
Heather R Cross et al. Am J Physiol Heart Circ Physiol. 2003 Feb.
Free article
Abstract
Recent studies suggest a role for phospholamban phosphorylation during ischemia and reperfusion. The role of phospholamban in ischemia was studied by subjecting hearts from male and female wild-type (MWT/FWT) and phospholamban-knockout (MKO/FKO) mice to 20 min of ischemia-40 min of reperfusion while (31)P NMR spectra were acquired. ATP and pH values fell lower during ischemia, and postischemic contractility was less, in MKO and FKO versus WT hearts. After shorter ischemia (15 min), recoveries of contraction, ATP, and pH were greater in FKO than MKO hearts. To examine the role of nitric oxide (NO) synthases (NOS) in the protection in FKO versus MKO hearts, we utilized 1 microM l-NAME, a NOS inhibitor, or 100 microM S-nitroso-N-acetylpenicillamine (SNAP), an NO donor. Recoveries of function, ATP, and pH were less in l-NAME-treated FKO than untreated FKO hearts and greater in SNAP-treated MKO than untreated MKO hearts. In conclusion, phospholamban ablation increased ischemic injury in both males and females; however, female hearts were less susceptible than male hearts. Protection in females was decreased by a NOS inhibitor and mimicked in males by an NO donor, implying that protection was NOS mediated.
Similar articles
- Male and female mice overexpressing the beta(2)-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide.
Cross HR, Murphy E, Koch WJ, Steenbergen C. Cross HR, et al. Cardiovasc Res. 2002 Feb 15;53(3):662-71. doi: 10.1016/s0008-6363(01)00528-4. Cardiovasc Res. 2002. PMID: 11861037 - Ca(2+) loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury.
Cross HR, Murphy E, Steenbergen C. Cross HR, et al. Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H481-9. doi: 10.1152/ajpheart.00790.2001. Am J Physiol Heart Circ Physiol. 2002. PMID: 12124192 - Nitric oxide as a mediator of delayed pharmacological (A(1) receptor triggered) preconditioning; is eNOS masquerading as iNOS?
Bell RM, Smith CC, Yellon DM. Bell RM, et al. Cardiovasc Res. 2002 Feb 1;53(2):405-13. doi: 10.1016/s0008-6363(01)00472-2. Cardiovasc Res. 2002. PMID: 11827691
Cited by
- Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.
Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW 2nd, MacLennan DH, Kremastinos DT, Kranias EG. Haghighi K, et al. J Clin Invest. 2003 Mar;111(6):869-76. doi: 10.1172/JCI17892. J Clin Invest. 2003. PMID: 12639993 Free PMC article. - Age and ovariectomy abolish beneficial effects of female sex on rat ventricular myocytes exposed to simulated ischemia and reperfusion.
Ross JL, Howlett SE. Ross JL, et al. PLoS One. 2012;7(6):e38425. doi: 10.1371/journal.pone.0038425. Epub 2012 Jun 6. PLoS One. 2012. PMID: 22701638 Free PMC article. - Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy.
Peche VS, Holak TA, Burgute BD, Kosmas K, Kale SP, Wunderlich FT, Elhamine F, Stehle R, Pfitzer G, Nohroudi K, Addicks K, Stöckigt F, Schrickel JW, Gallinger J, Schleicher M, Noegel AA. Peche VS, et al. Cell Mol Life Sci. 2013 Feb;70(3):527-43. doi: 10.1007/s00018-012-1142-y. Epub 2012 Sep 4. Cell Mol Life Sci. 2013. PMID: 22945801 Free PMC article. - Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications.
Ostadal B, Ostadal P. Ostadal B, et al. Br J Pharmacol. 2014 Feb;171(3):541-54. doi: 10.1111/bph.12270. Br J Pharmacol. 2014. PMID: 23750471 Free PMC article. Review. - Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90.
Lam CK, Zhao W, Cai W, Vafiadaki E, Florea SM, Ren X, Liu Y, Robbins N, Zhang Z, Zhou X, Jiang M, Rubinstein J, Jones WK, Kranias EG. Lam CK, et al. Circ Res. 2013 Jan 4;112(1):79-89. doi: 10.1161/CIRCRESAHA.112.279935. Epub 2012 Sep 14. Circ Res. 2013. PMID: 22982986 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- HL-26057/HL/NHLBI NIH HHS/United States
- HL-37952/HL/NHLBI NIH HHS/United States
- R01 HL039752/HL/NHLBI NIH HHS/United States
- HL-64018/HL/NHLBI NIH HHS/United States
- P40RR12358/RR/NCRR NIH HHS/United States
- HL-52318/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases